HCV TRIALS

Two once-daily drugs may help clear HCV, trials indicate.

 

MedPage Today (11/3, Gever) reported, “Two investigational drugs targeting the hepatitis C virus (HCV) protease enzyme helped patients clear the virus with once-daily dosing, contrasting with the three-times-per-day schedule needed for similar drugs in development,” according to separate trials. Baylor College researchers found that “at least 85 percent of patients adding narlaprevir (formerly called SCH 900518) to pegylated interferon-alfa-2b (PEGIntron) and ribavirin (Rebetol) after four weeks achieved rapid virological responses, compared with no patients receiving only interferon and ribavirin.” The “investigational compound BI 201355″ produced “comparable results” in a study conducted by Johns Hopkins. Specifically, the “drug, also given once daily with interferon-ribavirin, led to HCV RNA becoming undetectable by week 12 in up to 90 percent of patients.” Notably, the aforementioned results are “from ongoing Phase II trials.”

289 Responses to “HCV TRIALS”

  1. CLIFTON says:

    nexium pepsin ac

    Buy_generic drugs…

  2. TERRY says:

    social interaction anxiety

    Buy_without prescription…

  3. FRED says:

    terry abbot

    Buy_generic drugs…

  4. ARTURO says:

    macon georgia drug court

    Buy_without prescription…

  5. RAMON says:

    regulations for dementia units

    Buy_drugs without prescription…

  6. SHANE says:

    sample ncp for diabetes

    Buy_without prescription…

  7. jordan says:

    Download@pop.Rock” rel=”nofollow”>.

    Buy rock US Charts…

  8. JORDAN says:

    side@effects.from.the.drug.protonix” rel=”nofollow”>…

    Buynow it…

  9. HUGH says:

    depo@provera.bone.loss” rel=”nofollow”>…

    Buygeneric drugs…

  10. JOHN says:

    canadian@pharmacy.valtrex” rel=”nofollow”>…

    Buygeneric meds…

  11. JACKIE says:

    benadryl dogs

    Buy_generic drugs…

Leave a Reply